Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System.

Purpose: Communication atypicalities are considered promising markers of a broad range of clinical conditions. However, little is known about the mechanisms and confounders underlying them. Medications might have a crucial, relatively unknown role both as potential confounders and offering an insigh...

Full description

Bibliographic Details
Published in:	Journal of Speech, Language & Hearing Research Vol. 66; no. 9; pp. 3242 - 3260
Main Authors:	Fusaroli, Michele, Simonsen, Arndis, Borrie, Stephanie A., Low, Daniel M., Parola, Alberto, Raschi, Emanuel, Poluzzi, Elisabetta, Fusaroli, Riccardo
Format:	Article
Published:	American Speech-Language-Hearing Association Sep2023
Subjects:	United States. Food & Drug Administration Psychoses Communicative disorders Affective disorders Drugs Drug side effects Statistics Parasympathomimetic agents Confidence intervals Pharmacology Data analysis Vascular endothelial growth factors Odds ratio Comorbidity Antipsychotic agents
Online Access:	View this record in EBSCOhost

Internet

View this record in EBSCOhost